Mezzion Pharma Announces Positive Data Presented to FDA in Type C Meeting

/PRNewswire/ -- Mezzion Pharma Co., Ltd. (Mezzion Pharma) announces that new data from its Phase 3 efficacy and safety trial (FUEL Trial) and its open label...

Related Keywords

Seoul ,Soult Ukpyolsi ,South Korea ,United States ,Boca Raton ,Florida ,Illinois ,Deerfield ,Canada ,James Yeager ,Mezzion Pharma ,Mezzion Pharma Co Ltd ,Pediatric Heart Network ,Mezzion Pharma Co ,Drug Administration ,Mezzion Pharmaceuticals Inc ,Heart Network ,Fontan Procedure ,Mezzion Pharmaceuticals ,Private Securities Litigation Reform Act ,